Skip to content

Psychological, Neurological and Immunological Changes Following a Meeting With a Chaplain Coupled With Biblical Readings

Hospital-based Ecumenical And Linguistical, Immuno- Neuro-Genetic (HEALING) Study - Randomized Clinical Trial - A Study on the Epigenetic Background of Neuro-immune-modulation in Clinical Environment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04112121
Acronym
HEALING
Enrollment
57
Registered
2019-10-02
Start date
2015-09-10
Completion date
2017-01-02
Last updated
2019-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospitalism

Keywords

faith, religion, hospitalization, immunology, psychoneuroimmunology, theology, fMRI

Brief summary

The aim of the HEALING (Hospital-based Ecumenical And Linguistic Immuno-NeuroloGic) Study was to examine immunological and neurological changes in hospitalized participants after meeting a chaplain and Biblical listenings, in order to evaluate whether these meetings affect the course of the disease.

Detailed description

The authors pre-screened hospitalized participants to find those who were the most in need of an intervention by a chaplain. A passage from the Bible was read to the participants during a meeting with the chaplain at the bedside, or in the chapel of the hospital. No meeting occurred in the randomized control group, which was compiled in a way to get a group of participants with an approximatively similar pattern of diagnoses and treatment days than the intervention groups. The pace of enrollment was deliberately slow in order to assure the authenticity of the visits (slow science). Blood samples were taken 30 minutes prior, and 60 minutes after the meeting to measure White Blood Cell (WBC)-, lymphocyte counts, interferon gamma (IFN-γ)-, immunoglobulin M (IgM)-, immunoglobulin A (IgA)-, immunoglobulin G (IgG)-, and complement C3 levels. A subgroup of the visited participants was subjected to functional Magnetic Resonance Imaging (fMRI), where they were played an audiotape of readings of the same passage from the Bible. Associative tests, paired-samples t-test, network analysis was performed to search for any correlation between psychological and immunological parameters, completed with Statistical Parametric Mapping to search for correlations of the above with neurological parameters.

Interventions

BEHAVIORALMeeting with a Chaplain coupled with Biblical Readings

Sponsors

Somogy Megyei Kaposi Mór Teaching Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

parallel, randomized, open-labeled, controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult age (\>18 years) * the condition of being hospitalized * the ability for verbal communication * alertness, orientation * no sign of psychosis in their medical history * willingness to participate in the study after written, informed consent

Exclusion criteria

* the inability to communicate verbally * psychotic state, altered mental state * unwillingness to participate * active and treated malignant disease * steroid, NSAID or metamizole- sodium use

Design outcomes

Primary

MeasureTime frameDescription
Change in lymphocyte countChange from baseline at 120 minuteslymphocyte count measured with automatised laboratory measurement and microscopic blood smear examination
Change in total white blood cell (WBC) countChange from baseline at 120 minutesWBC count measured with automatised laboratory measurement and microscopic blood smear examination
Change in interferon-gamma levelChange from baseline at 120 minutesenzyme-linked immunosorbent assay
Change in immunoglobulin M levelChange from baseline at 120 minutesenzyme-linked immunosorbent assay
Change in immunoglobulin A levelChange from baseline at 120 minutesenzyme-linked immunosorbent assay
Change in immunoglobulin G levelChange from baseline at 120 minutesenzyme-linked immunosorbent assay
Change in complement C3 levelChange from baseline at 120 minutesenzyme-linked immunosorbent assay
Change in functional Magnetic Resonance Imaging activityChange from baseline during the 60 second long activation blockStatistical Parametric Mapping analysis of Blood Oxygenation Level Dependent (BOLD) answers
Participants' satisfaction with the visit as assessed by Scores given on the Healing - after Questionnairewithin 1 hour after interventionParticipants' assessement of their satisfaction on single-item rating scales in a Questionnaire designed for the Study. Answers range from 1 to 5, with higher values representing better outcomes.
Chaplain's satisfaction with the visit as assessed by Scores given on the Healing - after Questionnairewithin 1 hour after interventionChaplain's assessement of her satisfaction on single-item rating scales in a Questionnaire designed for the Study. Answers range from 1 to 5, with higher values representing better outcomes.
Participants' level of distress in the month preceding the measurement as assessed with the total Score of the Perceived Stress Scale 14 (PSS-14)within 30 minutes before interventionPSS-14 Scale uses 14 questions with answers ranging from 0 to 4, with higher values indicating higher levels of distress on the seven negative-, and lower levels of distress on the seven positive items. Scores are obtained by reversing the scores on the seven positive items, then summing across all to give the total PSS-14 Score.
Participants' spiritual and psychological needs, religious practice, thoughts about how they became sick, and how they could heal, as assessed by Scores given on the Healing - before Questionnairewithin 30 minutes before interventionParticipants' assessement on single-item rating scales in a Questionnaire designed for the Study (Healing - before Questionnaire). Answers range from 1 to 5, with higher values representing better outcomes.

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026